Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases.

Swigris JJ, Brown KK, Abdulqawi R, Buch K, Dilling DF, Koschel D, Thavarajah K, Tomic R, Inoue Y.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180075. doi: 10.1183/16000617.0075-2018. Print 2018 Dec 31. Review.

2.

Optimization of patient-specific inhaler regimens with the use of the aerosol inhalation monitor.

Blum E, Thavarajah K, Martirosov AL.

J Am Pharm Assoc (2003). 2018 Dec 11. pii: S1544-3191(18)30442-4. doi: 10.1016/j.japh.2018.10.012. [Epub ahead of print]

PMID:
30552051
3.

Predischarge bundle for patients with acute exacerbations of COPD to reduce readmissions and ED visits: a randomized controlled trial.

Jennings JH, Thavarajah K, Mendez MP, Eichenhorn M, Kvale P, Yessayan L.

Chest. 2015 May;147(5):1227-1234. doi: 10.1378/chest.14-1123.

PMID:
25940250
4.

Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

Hinchcliff ME, Beaumont JL, Carns MA, Podlusky S, Thavarajah K, Varga J, Cella D, Chang RW.

J Rheumatol. 2015 Jan;42(1):64-72. doi: 10.3899/jrheum.140143. Epub 2014 Nov 1.

5.

Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form.

Hinchcliff M, Beaumont JL, Thavarajah K, Varga J, Chung A, Podlusky S, Carns M, Chang RW, Cella D.

Arthritis Care Res (Hoboken). 2011 Nov;63(11):1620-8. doi: 10.1002/acr.20591.

6.

Role of von Hippel-Lindau protein in fibroblast proliferation and fibrosis.

Zhou Q, Pardo A, Königshoff M, Eickelberg O, Budinger GR, Thavarajah K, Gottardi CJ, Jones J, Varga J, Selman M, Sznajder JI, Raj JU, Zhou G.

FASEB J. 2011 Sep;25(9):3032-44. doi: 10.1096/fj.10-177824. Epub 2011 Jun 3.

7.

Pulmonary complications of tumor necrosis factor-targeted therapy.

Thavarajah K, Wu P, Rhew EJ, Yeldandi AK, Kamp DW.

Respir Med. 2009 May;103(5):661-9. doi: 10.1016/j.rmed.2009.01.002. Epub 2009 Feb 7. Review.

8.

Rehabilitation after dialysis and kidney transplantation.

Toledo-Pereyra LH, Schneider A, Baskin S, McNichol L, Thavarajah K, Lin WJ, Whitten J.

Bol Asoc Med P R. 1985 Jun;77(6):227-30. No abstract available.

PMID:
3902043
9.

Treatment of multiple rejection episodes with ALG or ATGAM after cadaveric renal transplantation.

Toledo-Pereya LH, Whitten J, Baskin S, McNichol L, Thavarajah K, Lin W.

Bol Asoc Med P R. 1984 Jul;76(7):293-6. No abstract available.

PMID:
6383417
10.

Predictive survival after kidney transplantation. An analysis of risk factors.

Toledo-Pereyra LH, Zeichner WD, Baskin S, McNichol L, Lin W, Thavarajah K, Whitten J.

Am Surg. 1983 Nov;49(11):632-6.

PMID:
6357017
11.

Cadaver kidney allograft survival in a high-risk black population utilizing antilymphoblast globulin and low steroid therapy.

Mittal VK, Toledo-Pereyra LH, Baskin S, McNichol LJ, Thavarajah K, Lin W, Edford G, Whitten J, Allaben R.

Am Surg. 1983 Aug;49(8):436-9.

PMID:
6351686

Supplemental Content

Loading ...
Support Center